• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Quixnet Email
  • User Agreement

Welcome to Quixnet

  • Breaking News
  • World
  • US
  • Business
  • Sports
  • Technology

Eisai, Biogen receives U.S. FDA approval for Alzheimer’s drug, applies for full approval – Reuters

January 6, 2023 by quixnet

  1. Eisai, Biogen receives U.S. FDA approval for Alzheimer’s drug, applies for full approvalReuters
  2. FDA Approves, Leqembi, New Treatment for Early Alzheimer’sThe New York Times
  3. FDA greenlights new Alzheimer’s drug amid safety concernsNBC News
  4. Alzheimer’s drug lecanemab receives accelerated approval amid safety concernsCNN
  5. New Alzheimer’s drug offers hope to patients and caregivers | DW NewsDW News

Filed Under: Business

Primary Sidebar

Quote of the Day

Footer

Read More

  • Breaking News
  • World
  • US
  • Business
  • Sports
  • Technology

My Account & Help

  • Quixnet Email
  • User Agreement

Copyright © 2026 · Urban Communications Inc. · Log in